These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2887901)

  • 21. Angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
    Coats AJ
    Br J Hosp Med; 1987 Dec; 38(6):531-2, 536-41. PubMed ID: 2829986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P; Zuccalà A; Gaggi R
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased serum angiotensin-converting enzyme in end-stage renal disease.
    Rumpf KW; Brat A; Armstrong V; Scheler F
    Nephron; 1985; 40(2):248-9. PubMed ID: 2987717
    [No Abstract]   [Full Text] [Related]  

  • 24. Zinc, angiotensin I-converting enzyme and hypertension.
    Lockett CJ; Reyes AJ; Leary WP; Alcocer L; Olhaberry JV
    S Afr Med J; 1983 Dec; 64(26):1022-4. PubMed ID: 6316570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medical treatment of essential arterial hypertension].
    Degaute JP
    Rev Med Brux; 1983 Dec; 4(10):675-83. PubMed ID: 6140739
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinins, the long march--a personal view.
    Erdös EG
    Cardiovasc Res; 2002 Jun; 54(3):485-91. PubMed ID: 12031692
    [No Abstract]   [Full Text] [Related]  

  • 27. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
    Campese VM
    Am J Kidney Dis; 2007 Aug; 50(2):197-202. PubMed ID: 17660021
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monitoring angiotensin-converting enzyme inhibitors].
    Bolla B; Disdier P; Roux F; Renucci JF; Vaisse B; Harle JR; Poggi L; Weiller PJ
    Presse Med; 1994 Mar; 23(10):491. PubMed ID: 8022729
    [No Abstract]   [Full Text] [Related]  

  • 29. [Angiotensin-converting enzyme inhibitors: recent therapeutic aspect].
    Shionoiri H; Shigemasa T; Takasaki I
    Nihon Rinsho; 1997 Aug; 55(8):2067-74. PubMed ID: 9284425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough.
    Furuya K; Yamaguchi E; Hirabayashi T; Itoh A; Hizawa N; Ohnuma N; Kawakami Y
    Lancet; 1994 Feb; 343(8893):354. PubMed ID: 7905161
    [No Abstract]   [Full Text] [Related]  

  • 31. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensinogen t235 and angiotensin-converting enzyme insertion/deletion polymorphisms associated with the development of posttransplantation diabetes mellitus in renal allograft recipients.
    Özdemir BH; Özdemir FN; Ataç FB; Özdemir AA; Haberal M
    Transplant Proc; 2011 Mar; 43(2):572-4. PubMed ID: 21440764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of angiotensin-converting enzyme (ACE) inhibitors in hypertension and heart failure. Role of plasma versus tissue ACE.
    Dzau VJ
    Drugs; 1990; 39 Suppl 2():11-6. PubMed ID: 2160882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical topics: angiotensin I, converting enzyme inhibitor - a new antihypertensive agent].
    Iizuka T
    Kango; 1979 Oct; 31(10):100-1. PubMed ID: 228108
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in hypertensive patients with renal dysfunction.
    Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):230S-232S. PubMed ID: 2843197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension].
    Salvetti A; Pedrinelli R; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Cardiologia; 1984; 29(1-2):103-20. PubMed ID: 6085475
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency.
    Ramirez LM
    Am J Hypertens; 2002 Sep; 15(9):832-3. PubMed ID: 12219882
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
    Novikova LS; Arabidze GG
    Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
    Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
    Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.